Cargando…
Ibrutinib does not prevent kidney fibrosis following acute and chronic injury
Recent studies suggested that ibrutinib, a Bruton tyrosine kinase (BTK) inhibitor, developed for the treatment of chronic lymphocytic leukemia, may prevent NLRP3 inflammasome activation in macrophages, IL-1β secretion and subsequent development of inflammation and organ fibrosis. The role of NLRP3 h...
Autores principales: | Belliere, Julie, Casemayou, Audrey, Colliou, Eloïse, El Hachem, Hélène, Kounde, Clément, Piedrafita, Alexis, Feuillet, Guylène, Schanstra, Joost P., Faguer, Stanislas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184891/ https://www.ncbi.nlm.nih.gov/pubmed/34099830 http://dx.doi.org/10.1038/s41598-021-91491-x |
Ejemplares similares
-
Avacopan as First-Line Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Steroid-Sparing Option
por: Gabilan, Charlotte, et al.
Publicado: (2022) -
A single dose of estrogen during hemorrhagic shock protects against Kidney Injury whereas estrogen restoration in ovariectomized mice is ineffective
por: Buléon, Marie, et al.
Publicado: (2020) -
Kidney Involvement in Patients With Chronic Myelomonocytic Leukemia or BCR-ABL–Negative Myeloproliferative Neoplasms
por: Belliere, Julie, et al.
Publicado: (2020) -
Are serum C3 levels or kidney C3 deposits useful markers for predicting outcomes in patients with ANCA-associated vasculitis?
por: Cassard, Alexis, et al.
Publicado: (2023) -
The tryptophan pathway and nicotinamide supplementation in ischaemic acute kidney injury
por: Piedrafita, Alexis, et al.
Publicado: (2021)